PCV51 Cost of Acute Coronary Syndrome in Switzerland

Abstract

demographic characteristics, total health care utilization and cost burden were higher for patients who suffered a TIA after an NVAF diagnosis, relative to patients who did not. OBJECTIVES:To compare clinical outcomes and cost burden of patients who suffered a stroke during the 180 days after diagnosis of non-valvular atrial fibrillation (NVAF) with patients who did not. METHODS: Based on 2005-2007 US Medical insurance claim files, patients aged 65 years and older who have had two or more primary diagnoses of NVAF, occurring within 30 days of one another, were selected. The 180-day follow-up mortality rate, health care facility use and costs for patients with and without incidences of stroke were compared. Risk adjustment was performed using the propensity score matching (PSM) method with the ProbChoice™ algorithm. RESULTS: Out of patients who were identified with and without NVAF pre-stroke (nϭ18,195), 541 (2.97%) suffered a stroke during the 180 days after the NVAF diagnosis. After PSM risk-adjustment for pre-specified covariates, mortality (7.39% vs. 1.07% pϽ0.0001), outpatient emergency room (ER) visits (80.59% vs. 48.11% pϽ0.0001), readmission rates (1.85% vs. 0.40%, pϽ0.0001), transient ischemic attacks (44 vs. 8 /100 person years), and intracranial hemorrhage rates (71 vs. 7/100 person years) were all higher for patients who suffered a stroke compared to those who did not. Although risk-adjusted outpatient ER costs and office visit costs did not differ significantly between the two groups, patients who suffered a stroke had significantly higher inpatient ($24,231 vs. $15,137, pϽ0.0001) and total ($33,439 vs. $13,782, pϽ0.0001) expenditures. CONCLUSIONS: Most of the adverse events analyzed were higher for patients who suffered a stroke after an NVAF diagnosis relative to patients who did not. Total health care utilizations and health care costs were also significantly increased. OBJECTIVES:The objective of this study was to quantify, for the first time in a Spanish population, the time and cost burden of informal care for pts with heart failure. METHODS: A descriptive analysis of a multicenter, prospective observa-A373

Can a smoking ban save your heart?

“…Even in Switzerland, the second country in the world in terms of expectancy at birth (Organization for Economic Cooperation and Development, ), AMI is the leading cause of death, and it represents a huge economic burden. For instance, Wieser et al () estimate that in 2008, the total direct costs of acute coronary syndrome (of which AMIs represent more than 80% of the costs) were more than 1 billion Swiss Francs. To this large cost, we should add 500 million in indirect costs due to productivity losses.…”